Auxly FY22 Net Revenue Grows 13%, What About Adjusted EBITDA?

Zinger Key Points
  • Adjusted EBITDA was negative CA$16.9 million, an improvement of CA$4.8 million over the same period of 2021.
  • Net loss of CA$130.3 million compared to net loss of CA$33.7 million in 2021.

Auxly Cannabis Group Inc. XLY CBWTF 2022 total net revenue was CA$94.4 million, an increase of CA$10.6 million or 13% compared to 2021.

FY 2022 Financial Highlights

  • Gross profit of CA$16.5 million in 2022, a decrease of CA$2.8 million as compared to 2021, which includes the impacts of non-cash impairments and fair value adjustments.

  • Gross profit margin for 2022 was 17% versus 23% in 2021.

  • Net loss of CA$130.3 million compared to net loss of CA$33.7 million in 2021.

  • Adjusted EBITDA was negative CA$16.9 million, an improvement of CA$4.8 million over the same period of 2021.

Q4 2022 Financial Highlights

  • Adjusted EBITDA was negative CA$783,000, compared to negative CA$5.8 million in Q4 2021.

  • Net revenues of CA$24.7 million, approximately CA$4.6 million lower than the same period in 2021, however CA$4.9 million or 20% greater than Q3 2022.

Hugo Alves, CEO of Auxly, stated: "The Canadian cannabis industry faced numerous challenges in 2022 and Auxly was not immune to their impacts. To better position the company within current industry realities, we adapted our strategy in the third quarter by streamlining our focus to the three largest Canadian product categories of dried flower, pre-rolls, and vapes, leveraging our large-scale Leamington facility to deepen our competitive advantage and refining our cost structure.”

“Our efforts have yielded positive results, including our first significant wholesales of bulk dried flower from Auxly Leamington, improved net revenues and blended margins, and reductions in SG&A during the fourth quarter. We also internalized our sales team to improve relationships with retailers, strengthen distribution, and obtain new dried flower and pre-roll listings to increase category breadth and set the stage for further growth in 2023. We are encouraged by our recent achievements and remain dedicated to delivering further improvements in financial performance. I want to thank our talented team members for their continued commitment to Auxly's success."

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo by Jeff W on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsHugo Alvespremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.